What is LifeStance Health Group Inc. (LFST) Stock Return on Shareholders’ Capital?

LifeStance Health Group Inc. (NASDAQ: LFST) stock jumped 2.96% on Friday to $5.21 against a previous-day closing price of $5.06. With 0.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.53 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $5.36 whereas the lowest price it dropped to was $4.95. The 52-week range on LFST shows that it touched its highest point at $11.25 and its lowest point at $4.22 during that stretch. It currently has a 1-year price target of $7.92.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of LFST was down-trending over the past week, with a drop of -0.19%, but this was up by 10.85% over a month. Three-month performance dropped to -28.83% while six-month performance fell -19.97%. The stock lost -33.21% in the past year, while it has gained 5.47% so far this year. A look at the trailing 12-month EPS for LFST yields -0.79 with Next year EPS estimates of -0.35. For the next quarter, that number is -0.12. This implies an EPS growth rate of -26.00% for this year and 41.70% for next year.

Float and Shares Shorts:

At present, 357.52 million LFST shares are outstanding with a float of 317.91 million shares on hand for trading. On Oct 13, 2022, short shares totaled 9.98 million, which was 2.65% higher than short shares on Sep 14, 2022. In addition to Mr. Jesse Michael Bruff as the firm’s CFO & Treasurer, Mr. Kenneth Alan Burdick serves as its CEO & Chairman.

Institutional Ownership:

Through their ownership of 84.07% of LFST’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 63.19% of LFST, in contrast to 5.61% held by mutual funds. Shares owned by individuals account for 12.46%. As the largest shareholder in LFST with 7.57% of the stake, Fidelity Management & Research Co holds 28,473,323 shares worth 28,473,323. A second-largest stockholder of LFST, The Vanguard Group, Inc., holds 6,915,380 shares, controlling over 1.84% of the firm’s shares. Stockbridge Partners LLC is the third largest shareholder in LFST, holding 6,831,137 shares or 1.82% stake. With a 1.23% stake in LFST, the Fidelity Advisor Series I -Growth is the largest stakeholder. A total of 4,634,721 shares are owned by the mutual fund manager. The Fidelity Select Medical Technolog, which owns about 1.12% of LFST stock, is the second-largest Mutual Fund holder. It holds 4,219,743 shares valued at 20.85 million. Fidelity Select Port. – Health Ca holds 1.11% of the stake in LFST, owning 4,156,289 shares worth 20.53 million.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for LFST since 7 analysts follow the stock currently. There are 4 analysts who recommend BUY ratings, while 0 suggest SELL ratings. Of the remaining analysts, 3 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With LFST analysts setting a high price target of $10.00 and a low target of $6.50, the average target price over the next 12 months is $7.92. Based on these targets, LFST could surge 91.94% to reach the target high and rise by 24.76% to reach the target low. Reaching the average price target will result in a growth of 52.02% from current levels.

EPS: Estimates vs Actual

It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. LFST will report FY 2022 earnings on 03/08/2024. Analysts have provided yearly estimates in a range of -$0.58 being high and -$0.61 being low. For LFST, this leads to a yearly average estimate of -$0.60. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. LifeStance Health Group Inc. surprised analysts by $0.03 when it reported -$0.11 EPS against a consensus estimate of -$0.14. The surprise factor in the prior quarter was -$0.02. Based on analyst estimates, the high estimate for the next quarter is -$0.11 and the low estimate is -$0.13. The average estimate for the next quarter is thus -$0.12.

Summary of Insider Activity:

Insiders traded LFST stock several times over the past three months with 1 Buys and 4 Sells. In these transactions, 180,832 shares were bought while 122,390 shares were sold. The number of buy transactions has increased to 11 while that of sell transactions has risen to 26 over the past year. The total number of shares bought during that period was 1,268,878 while 1,186,322 shares were sold.

Leave a Comment

Your email address will not be published. Required fields are marked *